SCHEMBL16410743

SCHEMBL16410743

[N-]=[N+]=NCC(C=N)c1ccc(CN=NC2=Nc3ccccc3N(N)C23CCOCC3)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16410813 0.74 AMPD2 (0.33) —
SCHEMBL16410823 0.65 AMPD2 (0.34) —
SCHEMBL16410869 0.65 GAA (0.33) —
SCHEMBL16410814 0.64 — —
SCHEMBL16410684 0.62 — —
SCHEMBL16410849 0.62 — —
SCHEMBL16410660 0.62 TAAR1 (0.32) —
SCHEMBL16410844 0.60 — —
SCHEMBL16410726 0.59 ALDH1A1 (0.32) —
SCHEMBL16410731 0.57 KDM4E (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015007730-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2015-01-22 — — WO disclosed
Send feedback